AOD 9604 is a synthetic peptide analogue derived from the C-terminal fragment (amino acids 176–191) of human growth hormone (hGH). Unlike full-length hGH, AOD 9604 does not bind to the IGF-1 receptor or stimulate insulin-like growth factor production, making it a subject of particular interest in metabolic research where isolated lipolytic effects are under investigation.
The peptide is believed to mimic the fat-regulating properties of hGH by stimulating lipolysis (the breakdown of fat) and inhibiting lipogenesis (the formation of new fat cells), potentially through interaction with beta-3 adrenergic receptors. These characteristics have made AOD 9604 a focus of research into obesity, body composition, and metabolic regulation.
AOD 9604 has also attracted attention in studies related to cartilage and bone repair, with preliminary research suggesting potential regenerative properties in musculoskeletal tissue models.
Specifications: Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂ | Molecular Weight: 1815.1 g/mol | Purity: >98% | CAS Number: 221231-10-3 | Form: Lyophilised Powder.
Recommended storage is at –20°C, protected from light and moisture. Reconstitute with bacteriostatic water prior to use in research settings.
Molecular Formula
C₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight
1815.1 g/mol
Purity
>98%
CAS Number
221231-10-3
Form
Lyophilised Powder
Research Applications
Fat metabolism research, Lipolysis and lipogenesis studies, Obesity and body composition research, Metabolic regulation, Cartilage and bone repair studies, Growth hormone analogue research
For research purposes only. Not for human use.
Reviews
There are no reviews yet.